Solid Historical Cash Flow
| SLDB Stock | USD 5.70 0.01 0.18% |
Analysis of Solid Biosciences cash flow over time is an excellent tool to project Solid Biosciences LLC future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cashflows From Investing Activities of 71.4 M or Other Cashflows From Financing Activities of 140.6 K as it is a great indicator of Solid Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Solid Biosciences LLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Solid Biosciences LLC is a good buy for the upcoming year.
Solid |
About Solid Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Solid balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Solid's non-liquid assets can be easily converted into cash.
Solid Biosciences Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Solid Biosciences LLC to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Solid Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Solid Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Solid Biosciences LLC current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At present, Solid Biosciences' Investments are projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 8.3 M, whereas Sale Purchase Of Stock is forecasted to decline to about 69.6 M.
Solid Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Solid Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Solid Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 57.9M | 19.3M | 134.9M | 72.6M | 83.5M | 69.6M | |
| Investments | (31.5M) | 7.5M | (141.2M) | (182.8M) | 30.5M | 32.0M | |
| Change In Cash | (10.3M) | 78.7M | (33.9M) | 36.0M | (81.4M) | (77.3M) | |
| Stock Based Compensation | 14.2M | 11.6M | 13.4M | 7.5M | 7.6M | 8.3M | |
| Free Cash Flow | (97.1M) | (57.5M) | (79.0M) | (101.0M) | (95.7M) | (100.5M) | |
| Change In Working Capital | 7.8M | 16.2M | (23.0M) | (3.7M) | (6.3M) | (6.0M) | |
| Begin Period Cash Flow | 86.7M | 76.4M | 155.1M | 121.2M | 155.4M | 84.5M | |
| Total Cashflows From Investing Activities | 24.5M | 6.6M | (91.1M) | 59.2M | 68.0M | 71.4M | |
| Other Cashflows From Financing Activities | 8.6M | (3.8M) | 107K | 203K | 148K | 140.6K | |
| Depreciation | 2.8M | 3.9M | 3.0M | 2.4M | 2.6M | 2.1M | |
| Other Non Cash Items | (277K) | (20K) | (81K) | (18.3M) | (2.0M) | (2.1M) | |
| Capital Expenditures | 4.4M | 899K | 1.3M | 3.0M | 1.5M | 2.7M | |
| Total Cash From Operating Activities | (92.7M) | (56.6M) | (77.8M) | (98.0M) | (94.2M) | (98.9M) | |
| Change To Operating Activities | (1.2M) | 4.0M | (1.1M) | (11.5M) | (10.4M) | (9.8M) | |
| Net Income | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (96.0M) | (100.8M) | |
| Total Cash From Financing Activities | 57.9M | 128.7M | 135.0M | 74.8M | 3.1M | 3.0M | |
| End Period Cash Flow | 76.4M | 155.1M | 121.2M | 157.2M | 74.0M | 92.8M | |
| Other Cashflows From Investing Activities | 60.4M | 7.9M | 51.4M | 244.9M | 281.7M | 295.8M | |
| Change To Netincome | 14.2M | 11.6M | 13.5M | 7.5M | 8.7M | 7.7M | |
| Change To Liabilities | 3.3M | 17.3M | (13.7M) | (7.5M) | (6.7M) | (6.4M) | |
| Cash And Cash Equivalents Changes | (10.3M) | 78.7M | (33.9M) | 36.0M | 32.4M | 16.8M | |
| Cash Flows Other Operating | 4.5M | 30K | (9.3M) | (14.8M) | (13.3M) | (12.6M) | |
| Issuance Of Capital Stock | 49.3M | 132.5M | 134.9M | 72.6M | 75.1M | 79.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.04) | Quarterly Revenue Growth (1.00) | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.